Microsoft has announced plans to broaden its partnership with NVIDIA to leverage...
Bristol Myers Squibb (BMS) has concluded the acquisition of Karuna Therapeutics ...
TB is the leading determiner of death in patients with HIV, yet while new drug r...
The new initiative aims to spur innovation and mobilisation of sectors to drive ...
Madrigal’s Rezdiffra received an accelerated approval as a treatment for noncirr...
Biotheus has announced an expansion of its strategic partnership with Hansoh Pha...
Anocca has entered a licensing agreement with EmendoBio for the use of the latte...
Noramco has announced the launch of Noramco Group, a North American pharmaceutic...
The US FDA has approved BeiGene's TEVIMBRA for oesophageal squamous cell carcino...
Andy Molnar, CEO of the Digital Therapeutics Alliance, discusses the latest tren...
The new drug application included data from the Phase III eXalt3 study, publishe...
Originally operating as a subsidiary under BeiGene, Pi Health has become an inde...
Amidst the many BTK inhibitors, Breyanzi will be the first and only CAR-T cell t...
The committee ultimately backed the benefits of imetelstat based on data from th...
Research puts the spotlight on potential financial conflicts of interest (COI) a...
